Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valeriu Crudu

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Journal of the American Medical Informatics Association : JAMIA|February 9, 2022
Integrating landmark modeling framework and machine learning algorithms for dynamic prediction of tuberculosis treatment outcomesMaryam Kheirandish, Donald Catanzaro, Valeriu Crudu, et al.
Bulletin of the World Health Organization|February 1, 2008
Increasing tuberculosis case detection: lessons from the Republic of MoldovaViorel Soltan, Asma Khalid Henry, Valeriu Crudu, et al.
The European Respiratory Journal|October 14, 2017
High-dose isoniazid in the shorter-course multidrug-resistant tuberculosis regimen in the Republic of MoldovaDumitru Chesov, Nelly Ciobanu, Christoph Lange, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 4, 2017
MDR-TB in Eastern Europe in the era of the TB elimination action frameworkAndrii Dudnyk, Dmytro Butov, Valeriu Crudu, et al.
Journal of Clinical Microbiology|February 4, 2012
First evaluation of an improved assay for molecular genetic detection of tuberculosis as well as rifampin and isoniazid resistancesValeriu Crudu, Ecaterina Stratan, Elena Romancenco, et al.
Molecular Biology and Evolution|January 29, 2019
Beyond the SNP Threshold: Identifying Outbreak Clusters Using Inferred TransmissionsJames Stimson, Jennifer Gardy, Barun Mathema, et al.
The European Respiratory Journal|October 14, 2017
Lack of evidence of isoniazid efficacy for the treatment of MDR/XDR-TB in the presence of the <i>katG</i> 315T mutationDumitru Chesov, Nelly Ciobanu, Christoph Lange, et al.
The European Respiratory Journal|February 22, 2014
High risk and rapid appearance of multidrug resistance during tuberculosis treatment in MoldovaHelen E Jenkins, Valeriu Crudu, Viorel Soltan, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|April 3, 2025
Diagnostic accuracy study of STANDARD TB-Feron FIA and STANDARD TB-Feron ELISA tests for tuberculosis infection diagnosis in Eastern European settingValeriu Crudu, Dumitru Chesov, Alexandru Codreanu, et al.
Plos One|March 19, 2015
Combined antigen-specific interferon-γ and interleukin-2 release assay (FluoroSpot) for the diagnosis of Mycobacterium tuberculosis infectionDumitru Chesov, Christoph Lange, Franziska Daduna, et al.
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Journal of the American Medical Informatics Association : JAMIA|February 9, 2022
Integrating landmark modeling framework and machine learning algorithms for dynamic prediction of tuberculosis treatment outcomesMaryam Kheirandish, Donald Catanzaro, Valeriu Crudu, et al.
Bulletin of the World Health Organization|February 1, 2008
Increasing tuberculosis case detection: lessons from the Republic of MoldovaViorel Soltan, Asma Khalid Henry, Valeriu Crudu, et al.
The European Respiratory Journal|October 14, 2017
High-dose isoniazid in the shorter-course multidrug-resistant tuberculosis regimen in the Republic of MoldovaDumitru Chesov, Nelly Ciobanu, Christoph Lange, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 4, 2017
MDR-TB in Eastern Europe in the era of the TB elimination action frameworkAndrii Dudnyk, Dmytro Butov, Valeriu Crudu, et al.
Journal of Clinical Microbiology|February 4, 2012
First evaluation of an improved assay for molecular genetic detection of tuberculosis as well as rifampin and isoniazid resistancesValeriu Crudu, Ecaterina Stratan, Elena Romancenco, et al.
Molecular Biology and Evolution|January 29, 2019
Beyond the SNP Threshold: Identifying Outbreak Clusters Using Inferred TransmissionsJames Stimson, Jennifer Gardy, Barun Mathema, et al.
The European Respiratory Journal|October 14, 2017
Lack of evidence of isoniazid efficacy for the treatment of MDR/XDR-TB in the presence of the <i>katG</i> 315T mutationDumitru Chesov, Nelly Ciobanu, Christoph Lange, et al.
The European Respiratory Journal|February 22, 2014
High risk and rapid appearance of multidrug resistance during tuberculosis treatment in MoldovaHelen E Jenkins, Valeriu Crudu, Viorel Soltan, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|April 3, 2025
Diagnostic accuracy study of STANDARD TB-Feron FIA and STANDARD TB-Feron ELISA tests for tuberculosis infection diagnosis in Eastern European settingValeriu Crudu, Dumitru Chesov, Alexandru Codreanu, et al.
Plos One|March 19, 2015
Combined antigen-specific interferon-γ and interleukin-2 release assay (FluoroSpot) for the diagnosis of Mycobacterium tuberculosis infectionDumitru Chesov, Christoph Lange, Franziska Daduna, et al.
Pageof 8